PMID 40721737

Research
All papers

Supramaximal high-intensity interval training for older adults in a community setting: a pragmatic feasibility study

Question

Can a previously researched supramaximal cycling HIT program be feasibly implemented for older adults in a community training facility?

Summary

A 3-month community feasibility study adapted supramaximal cycling intervals for older adults. Attendance was high among completers and participants often found the format engaging, but the 6-second watt-based intervals were complex to manage. Four of 21 participants reported adverse events, none serious.

Methodology

  • Twenty-one medically screened older adults in a Swedish community facility.
  • 21 participants.
  • Indoor cycling.
  • Work intervals: 6 seconds.
  • Recovery: 54 seconds.
  • Intensity: Individual watts based on 60% of estimated maximum mean 6-second power.
  • 20 minutes.
  • 2 sessions/week.
  • 3 months; 25 sessions.
  • Single-arm pragmatic mixed-methods feasibility study
  • Feasibility, Adverse events, and Power and VO2max were tracked.

Outcomes

Attendance

Completers attended most sessions.

Median 88%, range 40-100%.

Improved

Fitness estimates

Completers showed positive median changes in 6-second power and VO2max, with individual variation.

Power +42 W (+13%); VO2max +0.6 ml/kg/min (+2.5%).

Improved

Feasibility

Participants found the program engaging, but short intervals and watt management were complex.

Qualitative/descriptive.

Mixed

Safety

Four participants reported adverse events; none were serious.

13 events total; musculoskeletal n=8, equipment n=5, cardiorespiratory n=3, disease n=1.

Mixed

Insights

  • Older-adult supramaximal intervals may need app/timer support or programmable bikes to reduce complexity.
  • Medical screening, instructor support, and clear progression rules were important confidence and safety features.

Limitations

  • Single-arm feasibility study.
  • Small volunteer sample.
  • Prespecified sample size not reached.
  • No formal effectiveness testing.

Safety

  • Four of 21 participants reported adverse events; 13 events total and none serious.
  • Reported issues included musculoskeletal events, equipment-related discomfort, cardiorespiratory symptoms including chest discomfort that was medically investigated without treatment, and increased symptoms from inflammatory disease.